Has evidence-based psychosocial treatment for anxiety disorders permeated usual care in community mental health settings?

Behaviour Research and Therapy

Volumn 72, Issue , 2015, Pages 9-17

  Wolitzky Taylor, Kate ^a   Zimmermann, Martha ^a   Arch, Joanna J ^b   De Guzman, Earl ^a   Lagomasino, Isabel ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Anxiety disorders; Cognitive behavioral therapy; Community mental health; Exposure therapy; Implementation in usual care

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMMUNITY CARE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE ACCESS; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PSYCHOSOCIAL CARE; SOCIAL SUPPORT; THERAPY EFFECT; ANXIETY DISORDERS; HEALTH CARE DELIVERY; IMPLOSIVE THERAPY; PATIENT PREFERENCE; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; ANXIETY DISORDERS; COGNITIVE THERAPY; COMMUNITY MENTAL HEALTH SERVICES; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMPLOSIVE THERAPY; MALE; PATIENT PREFERENCE; TREATMENT OUTCOME;

EID: 84935423003     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2015.06.010     Document Type: Article

References (60)

1. Arch J.J. Cognitive behavioral therapy and pharmacotherapy for anxiety: predictors of treatment preference among pregnant and non-pregnant women. Behaviour Research and Therapy 2014, 52:53-60.
2. Arch J.J., Craske M.G. Implications of naturalistic use of pharmacotherapy in CBT treatment of panic disorder. Behaviour Research and Therapy 2007, 45(7):1435-1447.
3. Arch J.J., Craske M.G. First line treatment: a critical appraisal of CBT developments and alternatives. Psychiatric Clinics of North America 2009, 32:525-547.
4. Arch J.J., Twohig M., Deacon B., Landy L.N., Bluett E. The credibility of exposure therapy: does theoretical rationale matter?. Behaviour Research and Therapy 2015, in press.
5. Barlow D.H. Anxiety and its disorders: The nature and treatment of anxiety and panic 2002, The Guilford Press, New York.
6. Barlow D.H., Allen L.B., Choate M.L. Toward a unified treatment for emotional disorders. Behavior Therapy 2004, 35(2):205-230.
7. Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. Journal of the American Medical Association 2000, 283(19):2529-2536.
8. Bieling P.J., McCabe R.E., Antony M.M. Cognitive-behavioral therapy in groups 2009, The Guilford Press.
9. Borntrager C.F., Chorpita B.F., Higa-McMillan C., Weisz J.R. Provider attitudes toward evidence-based practices: are the concerns with the evidence or with the manuals?. Psychiatric Services 2009, 60(5):677-681.
10. Butler A.C., Chapman J.E., Forman E.M., Beck A.T. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Review 2006, 26(1):17-31.
11. Chambless D.L., Ollendick T.H. Empirically supported psychological interventions: controversies and evidence. Annual Review of Psychology 2001, 52(1):685-716.
12. Chorpita B.F., Daleiden E.L., Weisz J.R. Modularity in the design and application of therapeutic interventions. Applied and Preventive Psychology 2005, 11:141-156.
13. Chorpita B.F., Taylor A.A., Francis S.E., Moffitt C., Austin A.A. Efficacy of modular cognitive behavior therapy for childhood anxiety disorders. Behavior Therapy 2004, 35(2):263-287.
14. Churchill R., Khaira M., Gretton V., Chilvers C., Dewey M., Duggan C., et al. Treating depression in general practice: factors affecting patients treatment preferences. British Journal of General Practice 2000, 50(460):905-906.
15. Clark D.M., Salkovskis P.M., Hackmann A., Wells A., Ludgate J., Gelder M. Brief cognitive therapy for panic disorder: a randomized controlled trial. Journal of Consulting and Clinical Psychology 1999, 67(4):583.
16. Cohen J., Mannarino A.P. Disseminating and implementing trauma-focused CBT in community settings. Trauma, Violence, & Abuse 2008, 9(4):214-226.
17. Cook J.M., O'Donnell C., Dinnen S., Bernardy N., Rosenheck R., Hoff R. Aformative evaluation of two evidence-based psychotherapies for PTSD in VA residential treatment programs. Journal of Traumatic Stress 2013, 26(1):56-63.
18. Craske M.G., Roy-Byrne P., Stein M.B., Sullivan G., Hazlett-Stevens H., Bystritsky A., et al. CBT intensity and outcome for panic disorder in a primary care setting. Behavior Therapy 2006, 37:112-119.
19. Deacon B.J., Abramowitz J.S. Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. Journal of Clinical Psychology 2004, 60(4):429-441.
20. Deacon B., Abramowitz J.S. Patients' perceptions of pharmacological and cognitive-behavioral treatments for anxiety disorders. Behavior Therapy 2005, 36:139-145.
21. Deacon B.J., Farrell N.R., Kemp J.J., Dixon L.J., Sy J.T., Zhang A.R., et al. Assessing therapist reservations about exposure therapy for anxiety disorders: the therapist beliefs about exposure scale. Journal of Anxiety Disorders 2013, 27(8):772-780.
22. Dwight-Johnson M., Lagomasino I., Hay J., Zhang L., Tang L., Green J., et al. Effectiveness of collaborative care in addressing depression treatment preferences among low-income Latinos. Psychiatric Services 2010, 61(11):1112-1118.
23. Dwight-Johnson M., Sherbourne C.D., Liao D., Wells K.B. Treatment preferences among depressed primary care patients. Journal of General Internal Medicine 2000, 15(8):527-534.
24. Farchione T.J., Fairholme C.P., Ellard K.K., Boisseau C.L., Thompson-Hollands J., Carl J.R., et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behavior Therapy 2012, 43(3):666-678.
25. Feeny N.C., Zoellner L.A., Mavissakalian M.R., Roy-Byrne P.P. What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women. Depression and Anxiety 2009, 26(8):724-731.
26. Foa E.B., Zoellner L.A., Feeny N.C., Hembree E.A., Alvarez-Conrad J. Does imaginal exposure exacerbate PTSD symptoms?. Journal of Consulting and Clinical Psychology 2002, 70(4):1022.
27. President's New Freedom Commission on Mental Health. (2004). Retrieved from http://www.mentalhealthcommission.gov/reports/FinalReport/toc.html.
28. Gallo K.P., Comer J.S., Barlow D.H. Direct-to-consumer marketing of psychological treatments for anxiety disorders. Journal of Anxiety Disorders 2013, 27:793-801.
29. Garcia H.A., Kelley L.P., Rentz T.O., Lee S. Pretreatment predictors of dropout from cognitive behavioral therapy for PTSD in Iraq and Afghanistan war veterans. Psychological Services 2011, 8(1):1.
30. Gibbons M.B.C., Rothbard A., Farris K.D., Stirman S.W., Thompson S.M., Scott K., et al. Changes in psychotherapy utilization among consumers of services for major depressive disorder in the community mental health system. Administration and Policy in Mental Health 2011, 38(6):495-503.
31. Goisman R.M., Warshaw M.G., Keller M.B. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. American Journal of Psychiatry 1999, 156:1819-1821.
32. Gould R.A., Otto M.W., Pollack M.H. Ameta-analysis of treatment outcome for panic disorder. Clinical Psychology Review 1995, 15(8):819-844.
33. Gould R.A., Otto M.W., Pollack M.H., Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: a preliminary meta-analysis. Behavior Therapy 1997, 28(2):285-305.
34. Gunter R.W., Whittal M.L. Dissemination of cognitive-behavioral treatments for anxiety disorders: overcoming barriers and improving patient access. Clinical Psychology Review 2010, 30(2):194-202.
35. Hansen N.B., Lambert M.J., Forman E.M. The psychotherapy dose-response effect and its implications for treatment delivery services. Clinical Psychology: Science and Practice 2002, 9(3):329-343.
36. Heimberg R.G., Becker R.E. Cognitive-behavioral group therapy for social phobia: Basic mechanisms and clinical strategies 2002, Guilford Press.
37. Hipol L.J., Deacon B.J. Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapists. Behavior Modification 2013, 37:170-188.
38. Hofmann S.G., Sawyer A.T., Korte K.J., Smits J.A. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. International Journal of Cognitive Therapy 2009, 2(2):160.
39. Insel T.R. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Archives of General Psychiatry 2009, 66:128-133.
40. Kohn L.T., Corrigan J.M., Donaldson M.S. Crossing the quality chasm: A new health system for the 21st century 2001, Committee on Quality of Health Care in America, Institute of Medicine, Washington, DC.
41. Lilienfeld S.O., Lynn S.J., Lohr J.M. Pseudoscience is alive and well. The scientific review of mental health practice: objective investigations of controversial and unorthodox claims in clinical psychology. Psychiatry, and Social Work 2003, 2(2):107-110.
42. Lopez M.A., Basco M.A. Effectiveness of cognitive behavioral therapy in public mental health: comparison to treatment as usual for treatment-resistant depression. Administration and Policy in Mental Health and Mental Health Services Research 2015, 42(1):87-98. http://dx.doi.org/10.1007/s10488-014-0546-4.
43. McLean C.P., Foa E.B. Dissemination and implementation of prolonged exposure therapy for posttraumatic stress disorder. Journal of Anxiety Disorders 2013, 27(8):788-792.
44. Öst L.G., Alm T., Brandberg M., Breitholtz E. One vs five sessions of exposure and five sessions of cognitive therapy in the treatment of claustrophobia. Behaviour Research and Therapy 2001, 39(2):167-183.
45. Öst L.G., Hellström K., Kåver A. One versus five sessions of exposure in the treatment of injection phobia. Behavior Therapy 1992, 23(2):263-281.
46. Otto M.W., Pollack M.H., Maki K.M. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology 2000, 68(4):556.
47. Otto M.W., Tolin D.F., Nations K.R., Utschig A.C., Rothbaum B.O., Hofmann S.G., et al. Five sessions and counting: considering ultra-brief treatment for panic disorder. Depression and Anxiety 2012, 29(6):465-470.
48. Roberge P., Marchand A., Reinharz D., Marchand L., Cloutier K. Economic evaluation of the cognitive-behavioral therapy of the anxiety disorders. Canadian Psychology 2004, 45(3):202-218.
49. Roshanaei-Moghaddam B., Pauly M.C., Atkins D.C., Baldwin S.A., Stein M.B., Roy-Byrne P. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?. Depression and Anxiety 2011, 28(7):560-567.
50. Roy-Byrne P., Craske M.G., Sullivan G., Rose R.D., Edlund M.J., Lang A.J., et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. Journal of the American Medical Association 2010, 303(19):1921-1928.
51. Santucci L.C., McHugh R.K., Barlow D.H. Direct-to-consumer marketing of evidence-based psychological interventions: Introduction. Behavior Therapy 2012, 43(2):231-235.
52. Stein M.B., Sherbourne C.D., Craske M.G., Means-Christensen A., Bystritsky A., Katon W., et al. Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry 2014, 161:2230-2237.
53. Stewart R.E., Chambless D.L. Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. Journal of Consulting and Clinical Psychology 2009, 77(4):595.
54. Stuart G.L., Treat T.A., Wade W.A. Effectiveness of an empirically based treatment for panic disorder delivered in a service clinic setting: 1-year follow-up. Journal of Consulting and Clinical Psychology 2000, 68(3):506.
55. Telch M.J., Lucas J.A., Schmidt N.B., Hanna H.H., Jaimez T.L., Lucas R.A. Group cognitive-behavioral treatment of panic disorder. Behaviour Research and Therapy 1993, 31(3):279-287.
56. Tolin D.F. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review 2010, 30:710-720.
57. Weissman M.M., Verdeli H., Gameroff M.J., Bledsoe S.E., Betts K., Mufson L., et al. National survey of psychotherapy training in psychiatry, psychology, and social work. Archives of General Psychiatry 2006, 63:925-934.
58. Weisz J.R., Chorpita B.F., Palinkas L.A., Schoenwald S.K., Miranda J., Bearman S.K., et al. Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trial. Archives of General Psychiatry 2012, 69(3):274-282.
59. Westra H.A., Stewart S.H. Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?. Clinical Psychology Review 1998, 18(3):307-340.
60. Young A.S., Klap R., Sherbourne C.D., Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry 2001, 58:55-61.